Chaetoglobosin A (ChA), a fungal extract produced by Penicillium aquamarinium, could effectively prevent the activation of chronic lymphocytic leukemia (CLL) cells and thus sensitize them to the PI3K and Bruton's tyrosine kinase (BTK) inhibitors treatment. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.